Form 4: Bausch + Lomb Director Buys $267K in Shares

Bausch + Lomb Director Steven H. Collis purchased 15,000 common shares and received 4,491 matching restricted share units.

Summary

• Steven H. Collis, a Director of Bausch + Lomb Corp (BLCO), acquired 15,000 common shares through open market purchases on February 23, 2026.
• The shares were purchased at a weighted average price of $17.81, totaling approximately $267,150.
• In connection with this purchase, Mr. Collis was granted 4,491 matching restricted share units (MRSUs) at a price of $0.
• These MRSUs will vest in three equal annual installments on the first, second, and third anniversaries of the grant date, contingent on his continued service.
• Following these transactions, Mr. Collis beneficially owns a total of 24,746 common shares directly.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as a director's personal investment of a substantial amount of capital, coupled with a long-term equity grant, demonstrates significant confidence in the company's future performance.

Positives

• A director's open market purchase of 15,000 common shares at $17.81 per share, totaling approximately $267,150, signals confidence in the company's future prospects.
• The grant of 4,491 matching restricted share units (MRSUs) aligns the director's interests with long-term shareholder value through a three-year vesting schedule.

Risks

• The matching restricted share units (MRSUs) are subject to a three-year vesting schedule, contingent on the director's continued service, meaning the full benefit is not immediate or guaranteed.

Future Outlook

The grant of matching restricted share units (MRSUs) indicates a future alignment of the director's incentives with the company's long-term performance, with vesting scheduled over the next three years, subject to continued service.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a director, is often interpreted by the market as a positive signal, suggesting that those closest to the company believe its shares are undervalued or expect future positive developments. This action is specific to Bausch + Lomb and its governance, rather than a broad industry trend.

Related Party Transactions

• Director Steven H. Collis, a related party, purchased 15,000 common shares of Bausch + Lomb Corp.
• Director Steven H. Collis, a related party, was granted 4,491 matching restricted share units.

Stakeholder Impact

• Shareholders: May view the director's share purchase as a positive indicator of confidence in the company's future, potentially leading to increased investor sentiment.
• Employees: No direct impact mentioned, but strong insider confidence can indirectly boost morale.

Next Steps

• One-third of the matching restricted share units (MRSUs) will vest on the first, second, and third anniversaries following the grant date (February 23, 2026), subject to continued service.

Key Dates

Recommendation

The director's significant open market purchase and the grant of matching restricted share units are strong signals of insider confidence, suggesting potential upside. While not a full investment thesis, this insider activity provides a positive data point for existing shareholders and those considering an investment, warranting a "hold" with a positive outlook.

Keywords

Bausch + Lomb, BLCO, Steven H. Collis, insider trading, Form 4, share purchase, restricted stock units, RSU, director, equity, beneficial ownership